Accelerate biotechnology
News
Congress schedule
Media Gallery

Batavia Biosciences receives $13.2M grant to accelerate market access of low-cost inactivated polio vaccine

Leiden, The Netherlands, February 25, 2019 – Batavia Biosciences announced today that it received a $13.2 million grant from the Bill & Melinda Gates Foundation to manufacture clinical-grade inactivated polio vaccine (sIPV), using its newly developed low-cost polio vaccine manufacturing process (marketed as HIP-IPVTM) based on the NevoLine™ manufacturing technology developed by Univercells. In 2016,…

Introduction breakthrough vaccine manufacturing platform

Univercells, a business-to-business provider focused on increasing the availability of affordable biologics to address global health challenges, announced today the commercial launch of its proprietary NevoLine™ bioproduction system for vaccines. The system was initially developed as part of a $12M Grand Challenges grant awarded by the Bill & Melinda Gates Foundation to deliver affordable inactivated polio vaccine (sIPV). Leading…

Batavia Biosciences partners with IAVI to advance development of vaccine against Lassa fever

Leiden, December 11th, 2018 – Batavia Biosciences announces today that the International AIDS Vaccine Initiative (IAVI) and Batavia Biosciences will work together under a grant to advance the development of a Lassa fever vaccine. With this grant, Batavia Biosciences will leverage its novel, highly intensified manufacturing technology to develop a low-cost, easy-to-implement manufacturing process. This…

Batavia Biosciences wins FD Gazelle Award for 4th consecutive year

We are proud to announce that Batavia Biosciences has again been awarded with an FD Gazelle Award 2018 by the leading Dutch financial newspaper, Financieel Dagblad as one of the fastest growing mid-sized companies of the Netherlands. It is the fourth time we have won an FD Gazelle Award and we hope that many more…

Batavia Biosciences is Best Biopharmaceutical CDMO 2018

Today, GHP Announces Winners of the Healthcare & Pharmaceutical Awards 2018. We are very proud to announce that Batavia Biosciences has been awarded “Best Biopharmaceutical Contract Development & Manufacturing Company 2018”. According to GHP: “The awards are given solely on merit and were awarded to commend those most deserving for their ingenuity and hard work, distinguishing…

CEO OF THE YEAR, 2018 title awarded to Batavia Biosciences!

We are pleased to announce that Dr. Menzo Havenga has been awarded the title CEO OF THE YEAR 2018- CONTRACT DEVELOPMENT AND MANUFACTURING. The European CEO Awards organization celebrates global business leaders that are making major strides in their respective fields. The organization recognizes product, service, functional, strategic, and managerial innovation in companies and individuals showing commercial insight and market integrity….

Menzo Havenga: Officer in the Order of Oranje-Nassau!

We are very proud that our CEO, Menzo Havenga, has been decorated in the Order of Orange-Nassau for his scientific achievements and his contributions to society. The Order of Orange-Nassau is a civil and military Dutch Royal order of chivalry founded on April 4, 1892. Menzo received the decorations that come with this distinction from…

Public-private consortium to propel Batavia Biosciences’ SATIRN technology for vaccine and antibody manufacturing

Leiden, 22 March 2018 – Leiden University has received a prestigious TTW-grant from the Netherlands Organization for Scientific Research (NWO) to collaborate with private partners ZoBio, and Batavia Biosciences to propel SATIRNTM technology, developed by Batavia Biosciences. The project aims to deliver, amongst others, better influenza vaccines. Under the TTW program, scientists from the partners…

Batavia Biosciences is the most innovative company 2017/2018 in the Netherlands

Brussels, 2 March 2018 – Batavia Biosciences has been selected as most innovative company in the Netherlands during an exclusive event held at the British Residence in Brussels for The European Business Awards, Europe’s largest business competition, sponsored by RSM. The award to Batavia was granted by a panel of independent judges including senior business…

Batavia Biosciences teams up with international consortium to support polio eradication

Leiden, 16 January 2018 – Today Batavia Biosciences announces its partnership with an international consortium coordinated by PATH aiming to develop and manufacture safer novel oral poliovirus vaccines (nOPV). The project, funded by the Bill & Melinda Gates Foundation, has the potential to bolster efforts to sustain a polio-free world after the disease has been…